pI: 8.3476 |
Length (AA): 596 |
MW (Da): 67092 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
22 | 596 | 2gmh (A) | 7 | 584 | 56.00 | 0 | 1 | 1.63587 | -0.62 |
51 | 104 | 3kd9 (A) | 4 | 77 | 34.00 | 0 | 0.9 | 0.531604 | -1.05 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128337)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G43400 | electron-transfer flavoprotein--ubiquinone oxidoreductase |
Brugia malayi | Bm1_15260 | hypothetical protein |
Brugia malayi | Bm1_57180 | Probable electron transfer flavoprotein-ubiquinone oxidoreductase,mitochondrial precursor |
Candida albicans | CaO19.3175 | similar to S. cerevisiae YOR356W |
Candida albicans | CaO19.10685 | similar to S. cerevisiae YOR356W |
Caenorhabditis elegans | CELE_C05D11.12 | Protein LET-721 |
Dictyostelium discoideum | DDB_G0278849 | electron transfer flavoprotein-ubiquinone oxidoreductase |
Drosophila melanogaster | Dmel_CG12140 | Electron transfer flavoprotein-ubiquinone oxidoreductase |
Escherichia coli | b0043 | putative oxidoreductase |
Escherichia coli | b1699 | putative oxidoreductase |
Homo sapiens | ENSG00000171503 | electron-transferring-flavoprotein dehydrogenase |
Leishmania braziliensis | LbrM.07.0660 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Leishmania donovani | LdBPK_070660.1 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Leishmania infantum | LinJ.07.0660 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Leishmania major | LmjF.07.0600 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Leishmania mexicana | LmxM.07.0600 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Loa Loa (eye worm) | LOAG_08143 | lethal protein 721 |
Mus musculus | ENSMUSG00000027809 | electron transferring flavoprotein, dehydrogenase |
Neospora caninum | NCLIV_040030 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Oryza sativa | 4349116 | Os10g0516300 |
Saccharomyces cerevisiae | YOR356W | Cir2p |
Schmidtea mediterranea | mk4.001794.00 | |
Trypanosoma brucei gambiense | Tbg972.8.780 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Trypanosoma brucei | Tb927.8.1240 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Trypanosoma congolense | TcIL3000_0_21750 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Trypanosoma congolense | TcIL3000_8_880 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Trypanosoma cruzi | TcCLB.508543.140 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Trypanosoma cruzi | TcCLB.506401.220 | electron transfer flavoprotein-ubiquinone oxidoreductase, putative |
Toxoplasma gondii | TGME49_265230 | electron transfer flavoprotein-ubiquinone oxidoreductase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1240 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1240 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1240 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.1240 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0043 | Escherichia coli | non-essential | goodall |
CELE_C05D11.12 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C05D11.12 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C05D11.12 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_265230 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.